VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
LNSRLENSAR, Inc.
$5.74$69M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

LNSR logoLENSAR, Inc.(LNSR)Earnings, Financials & Key Ratios

LNSR•NASDAQ
Price updated Jun 19, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryVision, dental, and ENT devices
AboutLENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.Show more
  • Revenue$58M+9.2%
  • EBITDA-$20M-198.1%
  • Net Income-$34M-9.2%
  • EPS (Diluted)-2.87-5.1%
  • Gross Margin46.41%-4.0%
  • EBITDA Margin-34.36%-172.9%
  • Operating Margin-42.06%-111.0%
  • Net Margin-58.66%

LNSR Key Insights

LENSAR, Inc. (LNSR) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong 5Y sales CAGR of 17.2%

✗Weaknesses

  • ✗Profits declining 11.6% over 5 years
  • ✗Weak Piotroski F-Score: 3/9
  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 13 (bottom 13%)
  • ✗Low quality earnings: Net income not backed by cash flow
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when LNSR posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

LNSR Price & Volume

LENSAR, Inc. (LNSR) stock price & volume — 10-year historical chart

Loading chart...

LNSR Growth Metrics

LENSAR, Inc. (LNSR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years17.24%
3 Years18.23%
TTM1.12%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM151.95%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM88.09%

Return on Capital

10 Years-38.54%
5 Years-34.67%
3 Years-34.42%
Last Year-59.84%

LNSR Recent Earnings

LENSAR, Inc. (LNSR) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 4/12 qtrs (33%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 8, 2026
Metric
Actual
Est
EPS
$2.99+1516.2%
$0.18
Rev
$13M-6.0%
$13M
Q2 2026
Mar 31, 2026
Metric
Actual
Est
EPS
$0.12-80.7%
$0.07
Rev
$13M-37.6%
$20M
Q4 2025
Nov 6, 2025
Metric
Actual
Est
EPS
$0.31-210.0%
$0.10
Rev
$14M-29.5%
$20M
Q3 2025
Aug 7, 2025
Metric
Actual
Est
EPS
$0.15-87.5%
$0.08
Rev
$14M-21.5%
$18M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 8, 2026
$2.99vs $0.18+1516.2%
$13Mvs $13M-6.0%
Q2 2026Mar 31, 2026
$0.12vs $0.07-80.7%
$13Mvs $20M-37.6%
Q4 2025Nov 6, 2025
$0.31vs $0.10-210.0%
$14Mvs $20M-29.5%
Q3 2025Aug 7, 2025
$0.15vs $0.08-87.5%
$14Mvs $18M-21.5%
Based on last 12 quarters of dataView full earnings history →

LNSR Peer Comparison

LENSAR, Inc. (LNSR) competitors in Vision, dental, and ENT devices — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
NVCR logoNVCRNovoCure LimitedDirect Competitor1.62B14.28-11.708.28%-25.66%-50.82%0.85
ALGN logoALGNAlign Technology, Inc.Product Competitor13.04B182.0832.230.9%10.5%10.7%0.03
ATRC logoATRCAtriCure, Inc.Product Competitor1.46B28.80-12014.88%-0.83%-0.95%0.18
LMAT logoLMATLeMaitre Vascular, Inc.Product Competitor2.14B93.9537.2813.53%24.35%16.19%0.47
OMCL logoOMCLOmnicell, Inc.Product Competitor1.78B39.05881.496.53%1.67%1.64%0.17
ABT logoABTAbbott LaboratoriesSupply Chain153.68B88.3811.574.59%31.88%27.26%0.32
BSX logoBSXBoston Scientific CorporationSupply Chain67.31B45.2923.3519.87%14.4%12.4%0.51
SYK logoSYKStryker CorporationSupply Chain117.88B307.8036.6411.16%12.92%15.04%0.66

Compare LNSR vs Peers

LENSAR, Inc. (LNSR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NVCR

Most directly comparable listed peer for LNSR.

Scale Benchmark

vs ABT

Larger-name benchmark to compare LNSR against a more recognizable public peer.

Peer Set

Compare Top 5

vs NVCR, ALGN, ATRC, LMAT

LNSR Income Statement

LENSAR, Inc. (LNSR) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
24.39M30.53M26.38M34.46M35.36M42.16M53.49M58.44M57.7M
Revenue Growth %
-25.18%-13.58%30.62%2.61%19.25%26.87%9.24%1.12%
Cost of Goods Sold
14.78M17.3M12.31M16.63M15.4M21.06M27.64M31.31M31.55M
COGS % of Revenue
60.59%56.67%46.65%48.25%43.56%49.94%51.68%53.59%-
Gross Profit
9.61M▲ 0%
13.23M▲ 37.6%
14.07M▲ 6.4%
17.83M▲ 26.7%
19.95M▲ 11.9%
21.11M▲ 5.8%
25.85M▲ 22.5%
27.12M▲ 4.9%
26.15M▲ 0%
Gross Margin %
39.41%43.33%53.35%51.75%56.44%50.06%48.33%46.41%45.32%
Gross Profit Growth %
-37.64%6.4%26.7%11.9%5.77%22.48%4.92%-
Operating Expenses
18.93M25.94M32.58M37.48M40.13M33.34M36.52M51.7M42.7M
OpEx % of Revenue
77.61%84.98%123.48%108.78%113.5%79.06%68.26%88.47%-
Selling, General & Admin
16.14M17.15M23.77M23.89M27.17M26.1M26.49M45.16M36.54M
SG&A % of Revenue
66.19%56.17%90.09%69.32%76.84%61.9%49.52%77.28%-
Research & Development
2.78M7.57M7.55M12.36M11.81M6.14M5.33M5.62M5.47M
R&D % of Revenue
11.42%24.79%28.63%35.86%33.41%14.56%9.96%9.62%-
Other Operating Expenses
01.23M1.26M1.24M1.15M1.1M4.7M921K689K
Operating Income
-9.32M▲ 0%
-12.71M▼ 36.5%
-18.5M▼ 45.5%
-19.65M▼ 6.2%
-20.18M▼ 2.7%
-12.23M▲ 39.4%
-10.66M▲ 12.8%
-24.58M▼ 130.5%
-16.55M▲ 0%
Operating Margin %
-38.2%-41.65%-70.13%-57.03%-57.06%-29%-19.94%-42.06%-28.68%
Operating Income Growth %
--36.47%-45.52%-6.22%-2.67%39.39%12.79%-130.45%-
EBITDA
-4.73M-8.85M-15.43M-16.89M-16.77M-8.71M-6.73M-20.08M-11.99M
EBITDA Margin %
-19.38%-28.98%-58.49%-49.01%-47.43%-20.67%-12.59%-34.36%-20.78%
EBITDA Growth %
--87.22%-74.41%-9.43%0.69%48.04%22.72%-198.13%-115.73%
D&A (Non-Cash Add-back)
4.59M3.87M3.07M2.76M3.41M3.52M3.93M4.5M4.56M
EBIT
-9.25M-12.66M-18.43M-19.65M-20.18M-12.23M-6.94M-24.58M-12.68M
Net Interest Income
0-2M-1.34M34K17K85K103K91K64K
Interest Income
3.27M0034K17K85K103K91K64K
Interest Expense
02M1.34M000000
Other Income/Expense
-3.26M-1.94M-1.27M51K263K-2.15M-20.74M-9.7M45.95M
Pretax Income
-12.57M▲ 0%
-14.66M▼ 16.6%
-19.77M▼ 34.9%
-19.6M▲ 0.9%
-19.91M▼ 1.6%
-14.38M▲ 27.8%
-31.4M▼ 118.3%
-34.28M▼ 9.2%
29.4M▲ 0%
Pretax Margin %
-51.55%-48.01%-74.95%-56.88%-56.32%-34.11%-58.71%-58.66%50.94%
Income Tax
20K00000000
Effective Tax Rate %
-0.16%0%0%0%0%0%0%0%0%
Net Income
-12.59M▲ 0%
-14.66M▼ 16.4%
-19.77M▼ 34.9%
-19.6M▲ 0.9%
-19.91M▼ 1.6%
-14.38M▲ 27.8%
-31.4M▼ 118.3%
-34.28M▼ 9.2%
29.4M▲ 0%
Net Margin %
-51.64%-48.01%-74.95%-56.88%-56.32%-34.11%-58.71%-58.66%50.94%
Net Income Growth %
--16.39%-34.91%0.87%-1.6%27.77%-118.34%-9.16%151.95%
Net Income (Continuing)
-12.59M-14.66M-19.77M-19.6M-19.91M-14.38M-31.4M-34.28M29.4M
Discontinued Operations
000000000
Minority Interest
000000000
EPS (Diluted)
-11.77▲ 0%
-1.57▲ 86.7%
-1.81▼ 15.3%
-2.10▼ 16.0%
-1.96▲ 6.7%
-1.31▲ 33.2%
-2.73▼ 108.4%
-2.87▼ 5.1%
1.91▲ 0%
EPS Growth %
-86.66%-15.29%-16.02%6.67%33.16%-108.4%-5.13%88.09%
EPS (Basic)
-11.77-1.57-1.81-2.10-1.96-1.31-2.73-2.87-
Diluted Shares Outstanding
1.07M10.64M10.93M9.37M10.16M10.97M11.52M11.96M15.42M
Basic Shares Outstanding
1.07M10.64M10.93M9.37M10.16M10.97M11.52M11.96M12.16M
Dividend Payout Ratio
---------

LNSR Balance Sheet

LENSAR, Inc. (LNSR) balance sheet — assets, liabilities & shareholders' equity

MetricDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
11.75M17.18M58.38M44.81M33.72M46.44M41.98M46.77M42.4M
Cash & Short-Term Investments
3.34M4.62M40.6M31.64M14.67M24.06M22.45M17.98M13.49M
Cash Only
3.34M4.62M40.6M31.64M14.67M20.62M16.26M12.97M12.49M
Short-Term Investments
000003.44M6.19M5M1M
Accounts Receivable
3.3M3.89M2.46M4.99M6.24M4.32M6.48M6.38M5.18M
Days Sales Outstanding
49.4246.4633.9852.8364.4237.4344.2139.8336.54
Inventory
4.06M8.06M13.47M6.49M11.74M15.69M11.43M21.52M23.1M
Days Inventory Outstanding
100.33170.15399.58142.43278.2271.95150.9250.85244.24
Other Current Assets
472K0001.06M2.37M1.62M896K625K
Total Non-Current Assets
17.14M17.35M20.73M21.65M22.13M23.14M24.32M24.66M23.82M
Property, Plant & Equipment
3.62M2.15M4.42M7.45M6.88M10.28M664K505K15.65M
Fixed Asset Turnover
6.74x14.19x5.98x4.63x5.14x4.10x80.56x115.71x6.91x
Goodwill
000000000
Intangible Assets
12.29M13.37M12.11M10.87M12.12M11.03M6.11M5.19M4.96M
Long-Term Investments
753K000442K492K1.16M02.32M
Other Non-Current Assets
476K1.84M4.21M3.34M3.13M1.34M16.38M18.96M2.55M
Total Assets
28.89M▲ 0%
34.54M▲ 19.6%
79.12M▲ 129.1%
66.47M▼ 16.0%
55.84M▼ 16.0%
69.58M▲ 24.6%
66.3M▼ 4.7%
71.43M▲ 7.7%
66.22M▲ 0%
Asset Turnover
0.84x0.88x0.33x0.52x0.63x0.61x0.81x0.82x0.83x
Asset Growth %
-19.56%129.09%-15.99%-15.98%24.61%-4.73%7.74%26.38%
Total Current Liabilities
7.66M7.83M8.47M8.71M11.42M11.63M15M40.57M17.8M
Accounts Payable
1.41M1.58M2.48M2.69M5.42M4.01M6M18.98M10.1M
Days Payables Outstanding
34.8833.2773.5859.14128.4869.4679.16221.26159.59
Short-Term Debt
653K0000000785K
Deferred Revenue (Current)
871K777K923K904K768K1.35M1.68M3.07M10.96M
Other Current Liabilities
1.98M4.67M2.97M3.38M3.52M4.01M5M15.05M1.64M
Current Ratio
1.53x2.19x6.90x5.14x2.95x3.99x2.80x1.15x2.38x
Quick Ratio
1.00x1.16x5.30x4.40x1.92x2.64x2.04x0.62x1.08x
Cash Conversion Cycle
114.88183.33359.98136.13214.13239.93115.9569.42121.19
Total Non-Current Liabilities
41.69M57.26M3.44M2.87M2.44M10.78M32.65M56.88M23.85M
Long-Term Debt
41.21M20.2M0000000
Capital Lease Obligations
0333K3.31M2.8M2.27M1.75M2.09M1.99M7.77M
Deferred Tax Liabilities
000000000
Other Non-Current Liabilities
479K36.73M129K69K167K9.03M30.56M54.89M21.25M
Total Liabilities
49.35M65.09M11.91M11.59M13.86M22.41M47.65M97.45M41.65M
Total Debt
41.21M20.53M3.81M3.31M2.8M2.31M2.61M2.73M2.57M
Net Debt
37.87M15.92M-36.79M-28.32M-11.87M-18.31M-13.65M-10.24M-9.92M
Debt / Equity
--0.06x0.06x0.07x0.05x0.14x-0.10x
Debt / EBITDA
---------0.21x
Net Debt / EBITDA
--------0.83x
Interest Coverage
--6.32x-13.76x------
Total Equity
-20.46M▲ 0%
-30.55M▼ 49.3%
67.21M▲ 320.0%
54.88M▼ 18.3%
41.98M▼ 23.5%
47.18M▲ 12.4%
18.65M▼ 60.5%
-26.02M▼ 239.5%
24.57M▲ 0%
Equity Growth %
--49.29%319.98%-18.35%-23.5%12.37%-60.48%-239.54%-702.24%
Book Value per Share
-19.13-2.876.155.854.134.301.62-2.181.59
Total Shareholders' Equity
-20.46M-30.55M67.21M54.88M41.98M47.18M18.65M-26.02M24.57M
Common Stock
96K11K109K110K111K113K116K120K121K
Retained Earnings
-23.53M-38.19M-57.99M-77.59M-97.51M-111.89M-143.29M-177.57M-141.24M
Treasury Stock
000000000
Accumulated OCI
-23.53M00004K6K4K0
Minority Interest
000000000

LNSR Cash Flow Statement

LENSAR, Inc. (LNSR) cash flow — operating, investing & free cash flow history

MetricDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-1.89M-12.59M-13.79M-8.97M-14.86M-9.66M-2.27M-14.83M-12.16M
Operating CF Margin %
-7.73%-41.24%-52.27%-26.03%-42.02%-22.91%-4.25%-25.38%-
Operating CF Growth %
--567.85%-9.55%34.96%-65.64%34.98%76.45%-551.91%-288.37%
Net Income
-12.59M-14.66M-19.77M-19.6M-19.91M-14.38M-31.4M-34.28M29.4M
Depreciation & Amortization
4.59M3.87M2.56M2.76M3.41M3.52M3.93M4.5M4.56M
Stock-Based Compensation
1.32M102K9.04M6.87M6.61M5.54M2.67M3.14M2.49M
Deferred Taxes
0-78K57K527K00000
Other Non-Cash Items
9.15M537K505K517K618K3.45M25.58M10.7M-26.81M
Working Capital Changes
5.92M-2.36M-6.19M-42K-5.58M-7.78M-3.04M1.1M-4.38M
Change in Receivables
443K14K1.33M-2.65M-1.44M1.08M-2.1M289K2.39M
Change in Inventory
-876K-4.77M-8.7M2.33M-6.89M-7.46M-4.9M-13.9M-11.21M
Change in Payables
663K127K910K213K2.73M-1.42M1.96M12.99M7.34M
Cash from Investing
-3.89M-2.09M-326K-354K-115K-4.16M-2.16M1.28M4.75M
Capital Expenditures
-3.25M-2.09M-366K-354K-115K-236K-156K-83K-77K
CapEx % of Revenue
13.32%6.84%1.39%1.03%0.33%0.56%0.29%0.14%0.13%
Acquisitions
-644K040K000000
Investments
---------
Other Investing
-644K00000000
Cash from Financing
6.96M15.95M50M361K-1.99M19.76M78K10.26M358K
Debt Issued (Net)
3.5M13.22M12.4M000000
Equity Issued (Net)
3.87M3.83M39.46M361K408K13.88M58K258K677K
Dividends Paid
-198K-31K-1.86M000000
Share Repurchases
000000000
Other Financing
-214K-1.07M00-2.4M5.88M20K10M-319K
Net Change in Cash
1.18M▲ 0%
1.27M▲ 7.9%
35.88M▲ 2723.3%
-8.96M▼ 125.0%
-16.96M▼ 89.3%
5.95M▲ 135.1%
-4.36M▼ 173.3%
-3.29M▲ 24.5%
-7.05M▲ 0%
Free Cash Flow
-5.13M▲ 0%
-14.68M▼ 186.0%
-14.16M▲ 3.5%
-9.32M▲ 34.1%
-14.97M▼ 60.6%
-9.89M▲ 33.9%
-2.43M▲ 75.4%
-14.91M▼ 513.5%
-12.24M▲ 0%
FCF Margin %
-21.05%-48.08%-53.66%-27.06%-42.34%-23.47%-4.54%-25.52%-21.21%
FCF Growth %
--185.95%3.55%34.15%-60.58%33.91%75.43%-513.49%-202.4%
FCF per Share
-4.80-1.38-1.29-0.99-1.47-0.90-0.21-1.25-0.79
FCF Conversion (FCF/Net Income)
0.15x0.86x0.70x0.46x0.75x0.67x0.07x0.43x-0.42x
Interest Paid
000000000
Taxes Paid
00019K3K18K24K42K42K

LNSR Key Ratios

LENSAR, Inc. (LNSR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2019202020212022202320242025TTM
Return on Equity (ROE)
--107.89%-32.11%-41.12%-32.26%-95.42%--514.92%
Return on Invested Capital (ROIC)
-689.23%-175.84%-51.74%-53.41%-31.1%-47.24%-94.44%
Gross Margin
43.33%53.35%51.75%56.44%50.06%48.33%46.41%45.32%
Net Margin
-48.01%-74.95%-56.88%-56.32%-34.11%-58.71%-58.66%50.94%
Debt / Equity
-0.06x0.06x0.07x0.05x0.14x-0.10x
Interest Coverage
-6.32x-13.76x------
FCF Conversion
0.86x0.70x0.46x0.75x0.67x0.07x0.43x-0.42x
Revenue Growth
25.18%-13.58%30.62%2.61%19.25%26.87%9.24%1.12%
Related:LNSR Dividend History·LNSR Revenue History·LNSR Price History·LNSR P/E History·LNSR Financial Ratios·LNSR Institutional Holders

LNSR SEC Filings & Documents

LENSAR, Inc. (LNSR) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 8, 2026·SEC

Material company update

Apr 15, 2026·SEC

Material company update

Mar 31, 2026·SEC

10-K Annual Reports

4
FY 2026

Mar 31, 2026·SEC

FY 2025

Feb 27, 2025·SEC

FY 2024

Mar 4, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 8, 2026·SEC

FY 2025

Nov 6, 2025·SEC

FY 2025

Aug 7, 2025·SEC

LNSR Frequently Asked Questions

LENSAR, Inc. (LNSR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

LENSAR, Inc. (LNSR) reported $57.7M in revenue for fiscal year 2025. This represents a 137% increase from $24.4M in 2018.

LENSAR, Inc. (LNSR) grew revenue by 9.2% over the past year. This is steady growth.

Yes, LENSAR, Inc. (LNSR) is profitable, generating $29.4M in net income for fiscal year 2025 (-58.7% net margin).

Dividend & Returns

LENSAR, Inc. (LNSR) had negative free cash flow of $12.2M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in LNSR back in 2018?

Total return calculator · dividends reinvested · 8+ years of data

See returns →

How much would $100/month in LNSR be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →